Pall completes $375M Senior Notes offering

Pall Corporation (NYSE: PLL) today announced that it has completed the previously announced public offering of its $375 million aggregate principal amount of 5.00% Senior Notes due June 15, 2020.

Pall plans to use the net proceeds from this offering to redeem the $280 million aggregate principal amount of its outstanding 6% Senior Notes due 2012 and for general corporate purposes.

Banc of America Securities LLC and J.P. Morgan Securities Inc. are acting as joint bookrunning managers for the offering of notes.

Posted in:

Tags:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Pall Corporation. (2019, June 24). Pall completes $375M Senior Notes offering. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20100619/Pall-completes-24375M-Senior-Notes-offering.aspx.

  • MLA

    Pall Corporation. "Pall completes $375M Senior Notes offering". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20100619/Pall-completes-24375M-Senior-Notes-offering.aspx>.

  • Chicago

    Pall Corporation. "Pall completes $375M Senior Notes offering". News-Medical. https://www.news-medical.net/news/20100619/Pall-completes-24375M-Senior-Notes-offering.aspx. (accessed November 22, 2024).

  • Harvard

    Pall Corporation. 2019. Pall completes $375M Senior Notes offering. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20100619/Pall-completes-24375M-Senior-Notes-offering.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pall's GeneDisc System helps German authorities screen for deadly E.coli strain